ABK Biomedical
HALIFAX, A5 · Biotechnology, Health Care, Other · 42 employees
ABK Biomedical is a company focused on researching, developing, and commercializing medical device therapies to improve treatment outcomes and the lives of patients with benign and malignant hypervascular tumors. ABK Biomedical holds intellectual property in the areas of inorganic polymer microspheres and unique administration systems. The company possesses advanced intellectual capital and its ow
Funding history
- Funding Round — $2.6M — Nov 2025
- Funding Round — $35.0M — Oct 2025
- Funding Round — $26.1M — May 2025
- Funding Round — $28.5M — Dec 2022
- Series series c — $30.0M — Dec 2022
Recent signals
- Nov 03, 2025: Raised $2.6M
- Oct 14, 2025: Raised $35.0M
- May 13, 2025: Raised $26.1M
- Dec 22, 2022: Raised $28.5M
- Dec 06, 2022: Raised $30.0M in Series series c
- Sep 23, 2022: Raised $18.1M
- Apr 22, 2019: Raised $28.5M
See plans & pricing → Track ABK Biomedical’s funding, hiring, and signals — with verified contacts — on Fundz.